Black Diamond Therapeutics, Inc. (BDTX)
BDTX Stock Price Chart
Explore Black Diamond Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze BDTX price movements and trends.
BDTX Company Profile
Discover essential business fundamentals and corporate details for Black Diamond Therapeutics, Inc. (BDTX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
31 Jan 2020
Employees
24.00
CEO
Mark A. Velleca
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penetrant inhibitor of EGFR mutations, including canonical, intrinsic resistance, and acquired resistance mutations; and BDTX-4933, a brain-penetrant inhibitor of oncogenic BRAF class I, II and III alterations. It has a strategic partnership with OpenEye Scientific Software, Inc. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
BDTX Financial Timeline
Browse a chronological timeline of Black Diamond Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 4 Nov 2025
EPS estimate is -$0.23.
Earnings released on 7 Aug 2025
EPS came in at -$0.19 surpassing the estimated -$0.25 by +24.00%.
Earnings released on 12 May 2025
EPS came in at $0.98 surpassing the estimated $0.02 by +4.80K%, while revenue for the quarter reached $70.00M , beating expectations by +150.00%.
Earnings released on 6 Mar 2025
EPS came in at -$0.28 surpassing the estimated -$0.31 by +9.68%.
Earnings released on 5 Nov 2024
EPS came in at -$0.28 surpassing the estimated -$0.37 by +24.32%.
Earnings released on 6 Aug 2024
EPS came in at -$0.36 surpassing the estimated -$0.39 by +7.69%.
Earnings released on 9 May 2024
EPS came in at -$0.35 surpassing the estimated -$0.44 by +20.45%.
Earnings released on 12 Mar 2024
EPS came in at -$0.34 surpassing the estimated -$0.47 by +27.66%, while revenue for the quarter reached $4.89M .
Earnings released on 6 Nov 2023
EPS came in at -$0.45 surpassing the estimated -$0.49 by +8.16%.
Earnings released on 11 Aug 2023
EPS came in at -$0.52 surpassing the estimated -$0.54 by +3.70%.
Earnings released on 9 May 2023
EPS came in at -$0.57 surpassing the estimated -$0.61 by +6.56%.
Earnings released on 9 Mar 2023
EPS came in at -$0.59 surpassing the estimated -$0.63 by +6.35%.
Earnings released on 8 Nov 2022
EPS came in at -$0.60 surpassing the estimated -$0.64 by +6.25%.
Earnings released on 9 Aug 2022
EPS came in at -$0.63 surpassing the estimated -$0.68 by +7.35%.
Earnings released on 11 May 2022
EPS came in at -$0.70 surpassing the estimated -$0.75 by +6.67%.
Earnings released on 17 Mar 2022
EPS came in at -$0.71 surpassing the estimated -$1.01 by +29.70%.
Earnings released on 8 Nov 2021
EPS came in at -$0.97 surpassing the estimated -$0.98 by +1.02%.
Earnings released on 12 Aug 2021
EPS came in at -$0.95 falling short of the estimated -$0.87 by -9.20%.
Earnings released on 7 May 2021
EPS came in at -$0.84 falling short of the estimated -$0.67 by -25.37%.
Earnings released on 25 Mar 2021
EPS came in at -$0.63 matching the estimated -$0.63.
Earnings released on 10 Nov 2020
EPS came in at -$0.50 surpassing the estimated -$0.53 by +5.66%.
BDTX Stock Performance
Access detailed BDTX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.